BioSpace News Archive

the most common malignant tumor. The first patient in the state was treated by Dr. Bailes, who is chairman of the department of neurosurgery and co-director of the NorthShore Neurological Institute.

Cytovia Therapeutics, Inc (“Cytovia”), an emerging biopharmaceutical company developing Natural Killer (NK) immunotherapies for cancer, today announces the appointment of Dr. Wei Li as acting Chief Scientific Officer (CSO), effective June 1, 2020. During her biotech career, Dr. Li co-founded two companies and built up extensive expertise in all aspects of drug research and development, including preclinical development and pharmacology, clinical d

Verity Pharmaceuticals Inc. is pleased to announce that as of May 29, 2020, Zeulide Depot™, a hormone therapy for the palliative treatment of prostate cancer, has been added as a General Benefit through the Ontario Drug Benefit Program.

According to the latest market report published by Persistence Market Research titled ‘Herpes Marker Testing Market: Global Industry Analysis (2012 – 2016) & Forecast (2017 – 2025)’, the global market is expected to be valued at US$ 481.8 Mn by 2025 and expand at a CAGR of 6.1% over the forecast period (2017–2025).

Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing treatments for immune-mediated diseases, today announced that it will host a virtual analyst event to discuss Principia’s unique precision bonding technology platform,

Spectrum Pharmaceuticals, Inc. (NASDAQ-GS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced that Lyndah K. Dreiling, M.D., MBA, has been named Senior Vice President, Clinical Development. “

Arcus Biosciences, Inc. (NYSE:RCUS), an oncology-focused biopharmaceutical company working to create best-in-class cancer therapies, today announced that management will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Wednesday, June 10, 2020 at 3:50 p.m. Eastern Time.

Tricida, Inc. announced that, due to public health concerns relating to the coronavirus pandemic and to protect the health of its employees, directors and stockholders, its 2020 annual meeting of stockholders will be held in a virtual-only format.

Transplant Genomics, Inc. and Viracor Eurofins, announce the formation of the Eurofins Transplant Medical and Scientific Advisory Board, employing diverse expertise and experience in transplantation technology development and clinical studies to enhance the clinical value of diagnostics throughout the transplant community.

ViewRay, Inc. announced grants of stock options and restricted stock units to Zach Stassen, Chief Financial Officer for the company.